Monday, April 11, 2022

Guangzhou closes to most arrivals as China's outbreak grows



from Yahoo News - Latest News & Headlines https://ift.tt/uCO1TwV
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001...